On Thursday, a Food and Drug Administration (FDA) advisory council recommended approval for an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the US.

Roching Holdings (SWX: RO), a Swiss developer of pharmaceutical and therapeutic medicines used in oncology, has agreed to acquire Ignyta (NASDAQ: RXRX), a US developer of personalized-medicine therapies designed for autoimmune diseases. 

Kindred Healthcare (NYSE: KND) will be acquired for $9.00 per share in cash by Humana (NYSE: HUM), TPG Capital, and Welsh, Carson, Anderson & Stowe (“WCAS”). The total consideration equates to approximately $4.1 billion.

UnitedHealth Group (NYSE: UNH) announced it will purchase the primary and urgent care unit of DaVita (NYSE: DVA) for $4.9 billion.